glp-1 drug How long should you take drugs? Study links longer use to lower heart risk Exploring the Neurological Questions Surrounding

Keeping a symptom diary noting the frequency, severity, and any associated symptoms can provide valuable information for clinical assessment

[DOI] [PubMed] [Google Scholar] 55.Fras Juan P, Davies MJ, Rosenstock J, Prez Manghi Federico C, Fernndez Land Laura, Bergman BK, Liu B, Cui X, Brown K, SURPASS-2 Investigators Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes

(Surgery for Obesity and Related Diseases, 2023) reported mean weight loss of approximately 10-12% with semaglutide in post-bariatric patients over 612 months, though results varied considerably between individuals

doi: 10.1056/NEJMcp2102062 233 DaviesMFrchLJeppesenOKPaksereshtAPedersenSDPerreaultLet al

Compounded versions of semaglutide and tirzepatide are not FDA-approved, and their safety and effectiveness have not been approved by the FDA

We know that these drugs are affecting insulin in the periphery in good ways, and we know that insulin goes into the brain, Bocarsly says